Profile - To The Moon

WilliamTeo

Posts · 174Posts · 174
Following · 0Following · 0
Followers · 0Followers · 0

- WilliamTeoWilliamTeo
  ·2021-08-13
  Good
  Here's Why I'm More Excited Than Ever After This Fintech's Second-Quarter Earnings
  This company has already delivered 20-bagger returns for me, but I don't plan to sell.
  Here's Why I'm More Excited Than Ever After This Fintech's Second-Quarter Earnings
  257 Comment
  Like
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-08-12
  All the way
  BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster
  BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo
  BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster
  383 1
  5
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-08-10
  Lose money
  251 Comment
  Like
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-08-10
  To the sun
  AMC shares rose 7% in premarket trading.
  AMC shares rose 7% in premarket trading. AMC Entertainment reported a narrower than expected loss fo
  AMC shares rose 7% in premarket trading.
  319 Comment
  1
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-08-10
  Pro
  Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time
  According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE
  Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time
  293 Comment
  Like
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-08-06
  All the way
  Sorry, this post has been deleted
  361 Comment
  1
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-07-31
  To the sun
  402 Comment
  Like
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-07-29
  $Ebang International Holdings Inc.(EBON)$not meant to be
  456 Comment
  Like
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-07-23
  Trash stock
  458 Comment
  Like
  Share
  Report
- WilliamTeoWilliamTeo
  ·2021-07-23
  To the moon
  The Damaging AMC Entertainment Data Point No One Is Paying Attention To
  This suggests that bankruptcy is still very much in play for America's top movie chain.
  The Damaging AMC Entertainment Data Point No One Is Paying Attention To
  420 1
  3
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3575416215572570","uuid":"3575416215572570","gmtCreate":1612342668405,"gmtModify":1613096802979,"name":"WilliamTeo","pinyin":"williamteo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":130,"tweetSize":174,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.03","exceedPercentage":"93.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"80.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":894761578,"gmtCreate":1628858017494,"gmtModify":1676529876690,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894761578","repostId":"2159294386","repostType":4,"repost":{"id":"2159294386","pubTimestamp":1628853120,"share":"https://ttm.financial/m/news/2159294386?lang=&edition=fundamental","pubTime":"2021-08-13 19:12","market":"us","language":"en","title":"Here's Why I'm More Excited Than Ever After This Fintech's Second-Quarter Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2159294386","media":"Motley Fool","summary":"This company has already delivered 20-bagger returns for me, but I don't plan to sell.","content":"<p><b>Square</b> (NYSE:SQ) has delivered incredible gains for early investors, but the company's growth and market opportunity certainly justify it. In this&nbsp;<i>Fool Live</i> video clip,&nbsp;<b>recorded on Aug. 2</b>, Fool.com contributor Matt Frankel, CFP, discusses Square's latest results with&nbsp;<i>Industry Focus&nbsp;</i>host Jason Moser, and explains why he isn't planning to sell a single share of the fintech giant.</p>\n<p><b>Jason Moser:</b> In regard to the quarterly results, because earnings came out along with this press release, and I was looking through those numbers for the quarter, Matt. And it was another really impressive quarter. I do think that the market likes this deal and perhaps, that's part of the enthusiasm behind the stock today. But I also believe that this was another strong quarter and really showed the rebound, particularly in that physical retail side, like you've talked about before. There was a pretty strong rebound in spending through Square's networks.</p>\n<p><b>Matt Frankel:</b> You really hit the nail on the head there because there is a big rebound here. Square, unlike <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b> (NASDAQ:PYPL), is more based on physical merchants. There's a lot of online businesses at Square, but they're very concentrated in physical retail. Gross profit was up 91% year over year. It's not that they grew by 91%, it's that the business rebounded because the second quarter of last year was pretty terrible for any type of physical retail. They were very profitable this quarter, that was a big standout to me, was just the profitability of the business. Over $200 million in net income is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest totals the company has ever posted. Comparing things to a couple of years ago, if you look at the gross payment volume of $38.8 billion in the seller ecosystem, that's almost 50% higher than it was at the same quarter in 2019 before the pandemic.</p>\n<p><b>Moser:</b> Wow.</p>\n<p><b>Frankel:</b> They are up by 50% over pre-pandemic levels. They still have almost $7 billion in cash on the balance sheet, which remember: They're not spending a dime on the Afterpay acquisition, that's all stock, so they're keeping that. One stat that stood out to me, and I'll end with this one on Square's earnings, on the Cash App side, I mentioned earlier that they hit 40 million active users. Their gross profit per active user now was $55 in the second quarter, so $55 per active user. That's 2 1/2 times as much as it was pre-pandemic. Square is doing a much better job of monetizing its Cash App user base, which is the key to profitability, as we're seeing reflected in the results. I like the quarter, I'm much more of a fan of their quarterly numbers than I am of the Afterpay acquisition. I'm not totally sold on the acquisition. I think it's a good fit, but I think they might be overpaying a little bit, but the numbers look great. Their business keeps growing and they're clearly rebounding. They're clearly a big beneficiary of the reopening. I can see that continuing for the rest of the year. Because if you remember, the first half of the second quarter was still pretty socially distance and masked up and capacity limitations. It wasn't until midway through May or so when most places started lifting their requirements.</p>\n<p><b>Moser:</b> Yeah. Even just a little bit. One thing I noticed, and I'd be interested in your perspective here because I am wondering if this is something that would be more temporary in nature just given what we've gone through over the past year and the economic stimulus that's been passed along: I saw inflows per monthly transacting active customer. Those inflows nearly doubled compared to a couple of years ago. They noted that these inflows, the gross in the inflows to the Cash App customer is really the primary driver of Cash App gross profit growth. We've seen a lot of inflows here for obvious reasons. Plenty of stimulus. Square has proven itself to be a part of the solution in giving people quicker access to their money. But I wonder: Could there be a lull in those inflows that we should expect over the course of the next year as we see monetary policy tighten a little bit? Obviously, stimulus won't be as significant. The flip side to that is that the employment picture continues to gain steam and people are just using those tools that Square is providing through Cash App. Those inflows keep coming. I wonder if there is maybe not a headwind&nbsp;there on the horizon in regard to those inflows.</p>\n<p><b>Frankel:</b> That's a good point. The goal is for Square to convert those inflows into lasting relationships that use other parts of their business. It's a question of whether they'll be able to do that successfully. Think of it in the context of <b><a href=\"https://laohu8.com/S/ZM\">Zoom</a></b> (NASDAQ:ZM). Obviously, not everyone is going to have virtual meetings for ever and ever after the pandemic, but it gets people into their ecosystem that they can then use to sell other products and services to, and that's really where the big value is coming from. The same thing applies here. It's the pandemic really. It's not going to last where people are saving their stimulus checks, because I don't see three or four stimulus checks per year coming indefinitely. That's not the point, though. The point is that that money brought people into Square's ecosystem because they made it very easy for people to deposit their stimulus checks and things like that into the accounts and really could bring people into their ecosystem that they could cross-sell different services and products. It's like, \"Oh, you deposited your stimulus check? Become a brokerage customer, make some investments through here, buy some Bitcoin.\" Engagement is really the key, and it seems so far like they've been able to engage their new users really well. It's a question of whether that will continue. The inflows, there will absolutely be a lull, unquestionably. We'll see what happens with the customer engagement and how well that all the new people they brought into the Cash App ecosystem in the past year and a half or so will translate into revenue down the road.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why I'm More Excited Than Ever After This Fintech's Second-Quarter Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why I'm More Excited Than Ever After This Fintech's Second-Quarter Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 19:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/heres-why-im-more-excited-than-ever-after-this-fin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Square (NYSE:SQ) has delivered incredible gains for early investors, but the company's growth and market opportunity certainly justify it. In this Fool Live video clip, recorded on Aug. 2, Fool.com ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/heres-why-im-more-excited-than-ever-after-this-fin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQ":"Block"},"source_url":"https://www.fool.com/investing/2021/08/13/heres-why-im-more-excited-than-ever-after-this-fin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159294386","content_text":"Square (NYSE:SQ) has delivered incredible gains for early investors, but the company's growth and market opportunity certainly justify it. In this Fool Live video clip, recorded on Aug. 2, Fool.com contributor Matt Frankel, CFP, discusses Square's latest results with Industry Focus host Jason Moser, and explains why he isn't planning to sell a single share of the fintech giant.\nJason Moser: In regard to the quarterly results, because earnings came out along with this press release, and I was looking through those numbers for the quarter, Matt. And it was another really impressive quarter. I do think that the market likes this deal and perhaps, that's part of the enthusiasm behind the stock today. But I also believe that this was another strong quarter and really showed the rebound, particularly in that physical retail side, like you've talked about before. There was a pretty strong rebound in spending through Square's networks.\nMatt Frankel: You really hit the nail on the head there because there is a big rebound here. Square, unlike PayPal (NASDAQ:PYPL), is more based on physical merchants. There's a lot of online businesses at Square, but they're very concentrated in physical retail. Gross profit was up 91% year over year. It's not that they grew by 91%, it's that the business rebounded because the second quarter of last year was pretty terrible for any type of physical retail. They were very profitable this quarter, that was a big standout to me, was just the profitability of the business. Over $200 million in net income is one of the highest totals the company has ever posted. Comparing things to a couple of years ago, if you look at the gross payment volume of $38.8 billion in the seller ecosystem, that's almost 50% higher than it was at the same quarter in 2019 before the pandemic.\nMoser: Wow.\nFrankel: They are up by 50% over pre-pandemic levels. They still have almost $7 billion in cash on the balance sheet, which remember: They're not spending a dime on the Afterpay acquisition, that's all stock, so they're keeping that. One stat that stood out to me, and I'll end with this one on Square's earnings, on the Cash App side, I mentioned earlier that they hit 40 million active users. Their gross profit per active user now was $55 in the second quarter, so $55 per active user. That's 2 1/2 times as much as it was pre-pandemic. Square is doing a much better job of monetizing its Cash App user base, which is the key to profitability, as we're seeing reflected in the results. I like the quarter, I'm much more of a fan of their quarterly numbers than I am of the Afterpay acquisition. I'm not totally sold on the acquisition. I think it's a good fit, but I think they might be overpaying a little bit, but the numbers look great. Their business keeps growing and they're clearly rebounding. They're clearly a big beneficiary of the reopening. I can see that continuing for the rest of the year. Because if you remember, the first half of the second quarter was still pretty socially distance and masked up and capacity limitations. It wasn't until midway through May or so when most places started lifting their requirements.\nMoser: Yeah. Even just a little bit. One thing I noticed, and I'd be interested in your perspective here because I am wondering if this is something that would be more temporary in nature just given what we've gone through over the past year and the economic stimulus that's been passed along: I saw inflows per monthly transacting active customer. Those inflows nearly doubled compared to a couple of years ago. They noted that these inflows, the gross in the inflows to the Cash App customer is really the primary driver of Cash App gross profit growth. We've seen a lot of inflows here for obvious reasons. Plenty of stimulus. Square has proven itself to be a part of the solution in giving people quicker access to their money. But I wonder: Could there be a lull in those inflows that we should expect over the course of the next year as we see monetary policy tighten a little bit? Obviously, stimulus won't be as significant. The flip side to that is that the employment picture continues to gain steam and people are just using those tools that Square is providing through Cash App. Those inflows keep coming. I wonder if there is maybe not a headwind there on the horizon in regard to those inflows.\nFrankel: That's a good point. The goal is for Square to convert those inflows into lasting relationships that use other parts of their business. It's a question of whether they'll be able to do that successfully. Think of it in the context of Zoom (NASDAQ:ZM). Obviously, not everyone is going to have virtual meetings for ever and ever after the pandemic, but it gets people into their ecosystem that they can then use to sell other products and services to, and that's really where the big value is coming from. The same thing applies here. It's the pandemic really. It's not going to last where people are saving their stimulus checks, because I don't see three or four stimulus checks per year coming indefinitely. That's not the point, though. The point is that that money brought people into Square's ecosystem because they made it very easy for people to deposit their stimulus checks and things like that into the accounts and really could bring people into their ecosystem that they could cross-sell different services and products. It's like, \"Oh, you deposited your stimulus check? Become a brokerage customer, make some investments through here, buy some Bitcoin.\" Engagement is really the key, and it seems so far like they've been able to engage their new users really well. It's a question of whether that will continue. The inflows, there will absolutely be a lull, unquestionably. We'll see what happens with the customer engagement and how well that all the new people they brought into the Cash App ecosystem in the past year and a half or so will translate into revenue down the road.","news_type":1},"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894990649,"gmtCreate":1628780633881,"gmtModify":1676529854066,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/894990649","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://ttm.financial/m/news/2158325931?lang=&edition=fundamental","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1},"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896402641,"gmtCreate":1628599016083,"gmtModify":1676529791712,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Lose money","listText":"Lose money","text":"Lose money","images":[{"img":"https://static.tigerbbs.com/942135289525db288b1954e466ab1309","width":"1080","height":"3610"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896402641","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":896406724,"gmtCreate":1628598970368,"gmtModify":1676529791680,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the sun","listText":"To the sun","text":"To the sun","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896406724","repostId":"1116005404","repostType":4,"repost":{"id":"1116005404","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628582673,"share":"https://ttm.financial/m/news/1116005404?lang=&edition=fundamental","pubTime":"2021-08-10 16:04","market":"us","language":"en","title":"AMC shares rose 7% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1116005404","media":"Tiger Newspress","summary":"AMC shares rose 7% in premarket trading.\nAMC Entertainment reported a narrower than expected loss fo","content":"<p>AMC&nbsp;shares rose 7% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/692b6fc550595ea189d7b6697732bdac\" tg-width=\"854\" tg-height=\"608\" referrerpolicy=\"no-referrer\">AMC Entertainment&nbsp;reported&nbsp;a narrower than expected loss for the second quarter while revenue topped estimates.</p>\n<p>AMC&nbsp;will begin accepting apex cryptocurrency&nbsp;<b>Bitcoin</b>&nbsp;as payment for move tickets and concessions by the end of this&nbsp;year.</p>\n<p>“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO&nbsp;<b>Adam Aron</b>&nbsp;said on&nbsp;the Q2 earnings call on Monday.</p>\n<p>Aron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC shares rose 7% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC shares rose 7% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-10 16:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AMC&nbsp;shares rose 7% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/692b6fc550595ea189d7b6697732bdac\" tg-width=\"854\" tg-height=\"608\" referrerpolicy=\"no-referrer\">AMC Entertainment&nbsp;reported&nbsp;a narrower than expected loss for the second quarter while revenue topped estimates.</p>\n<p>AMC&nbsp;will begin accepting apex cryptocurrency&nbsp;<b>Bitcoin</b>&nbsp;as payment for move tickets and concessions by the end of this&nbsp;year.</p>\n<p>“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO&nbsp;<b>Adam Aron</b>&nbsp;said on&nbsp;the Q2 earnings call on Monday.</p>\n<p>Aron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116005404","content_text":"AMC shares rose 7% in premarket trading.\nAMC Entertainment reported a narrower than expected loss for the second quarter while revenue topped estimates.\nAMC will begin accepting apex cryptocurrency Bitcoin as payment for move tickets and concessions by the end of this year.\n“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO Adam Aron said on the Q2 earnings call on Monday.\nAron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":319,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896406617,"gmtCreate":1628598943439,"gmtModify":1676529791688,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Pro","listText":"Pro","text":"Pro","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896406617","repostId":"1122891084","repostType":4,"repost":{"id":"1122891084","pubTimestamp":1628585720,"share":"https://ttm.financial/m/news/1122891084?lang=&edition=fundamental","pubTime":"2021-08-10 16:55","market":"us","language":"en","title":"Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time","url":"https://stock-news.laohu8.com/highlight/detail?id=1122891084","media":"Seeking Alpha","summary":"According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE ","content":"<ul>\n <li>According to two reports published in medRxiv, the mRNA vaccine developed by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;may be less effective than <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s&nbsp;against the Delta variant of the coronavirus,&nbsp;<i>Reuters reports</i>.</li>\n <li>The study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.</li>\n <li>Researchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.</li>\n <li>However, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.</li>\n <li>While both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.</li>\n <li>In a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.</li>\n <li>\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.</li>\n <li>In a study&nbsp;posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.</li>\n <li>The data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.</li>\n <li>Overall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.</li>\n <li>At all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.</li>\n <li>Among patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.</li>\n <li>\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.</li>\n <li>Israel has already started administering booster shots to people over the age of 60.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 16:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE may be less effective than Moderna, Inc.'s against the Delta variant of the coronavirus, Reuters ...</p>\n\n<a href=\"https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122891084","content_text":"According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE may be less effective than Moderna, Inc.'s against the Delta variant of the coronavirus, Reuters reports.\nThe study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.\nResearchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.\nHowever, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.\nWhile both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.\nIn a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.\n\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.\nIn a study posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.\nThe data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.\nOverall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.\nAt all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.\nAmong patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.\n\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.\nIsrael has already started administering booster shots to people over the age of 60.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893119227,"gmtCreate":1628245138469,"gmtModify":1703503866100,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893119227","repostId":"1135651416","repostType":4,"isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806534198,"gmtCreate":1627666751414,"gmtModify":1703494456187,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the sun","listText":"To the sun","text":"To the sun","images":[{"img":"https://static.tigerbbs.com/edc1f1e47b16e96a42d7ec21bf988e3c","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806534198","isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808042660,"gmtCreate":1627547020950,"gmtModify":1703492090475,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>not meant to be","listText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>not meant to be","text":"$Ebang International Holdings Inc.(EBON)$not meant to be","images":[{"img":"https://static.tigerbbs.com/481041af7db4ea49f66170c2f8001a68","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808042660","isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175423584,"gmtCreate":1627047386448,"gmtModify":1703483213119,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Trash stock","listText":"Trash stock","text":"Trash stock","images":[{"img":"https://static.tigerbbs.com/c2a7977bbebb8a789f10da9a7ff17a88","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175423584","isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175429165,"gmtCreate":1627047351657,"gmtModify":1703483211654,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/175429165","repostId":"2153498346","repostType":4,"repost":{"id":"2153498346","pubTimestamp":1627045620,"share":"https://ttm.financial/m/news/2153498346?lang=&edition=fundamental","pubTime":"2021-07-23 21:07","market":"us","language":"en","title":"The Damaging AMC Entertainment Data Point No One Is Paying Attention To","url":"https://stock-news.laohu8.com/highlight/detail?id=2153498346","media":"Motley Fool","summary":"This suggests that bankruptcy is still very much in play for America's top movie chain.","content":"<p>For nearly six months, meme stocks -- companies lauded more for the buzz they create on social media than their financial performance -- have been the talk of Wall Street. Often sporting high levels of short interest and poor outlooks, these meme stocks have been lifted up by an army of retail investors.</p>\n<p>Although there seems to be a new meme stock in play every day, movie theater chain <b>AMC Entertainment</b> (NYSE:AMC) has consistently been the most popular.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634412%2Fmovie-theater-popcorn-date-film-amc-regal-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"470\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Hope for a short squeeze is dwindling</h3>\n<p>Why AMC? According to its impassioned following, the company is purportedly ripe for a short squeeze. For those who may not be following AMC closely, the company's share price did squeeze short sellers (i.e., pessimists betting the share price will decline) in late January, shortly after the company saved itself from immediate bankruptcy by selling stock and issuing high-interest debt.</p>\n<p>The problem for this emotion-driven group of AMC enthusiasts, who call themselves \"apes\" -- a nod to <i>Rise of the Planet of the Apes</i> and the idea that apes are stronger together -- is that the prospect for a short squeeze on AMC is pretty poor. Between the end of May and the end of June, New York Stock Exchange-reported data shows that shares held short declined from 102.3 million to approximately 75.5 million... <i>and the price of AMC fell!</i></p>\n<p>Short sellers have to feel trapped in their positions for a squeeze to occur, and that's simply not happening with short interest on the decline and the short ratio (also known as \"days to cover\") well below <a href=\"https://laohu8.com/S/AONE.U\">one</a>. There's not a data point more closely followed by AMC shareholders than its short interest.</p>\n<p>What isn't being paid attention to, but is far more damaging to AMC and its shareholders, is the absolute rout in some of the company's bonds over the past two weeks.</p>\n<p><img src=\"https://static.tigerbbs.com/a7b31a2637d841cd0aa4afe72af35c5e\" tg-width=\"700\" tg-height=\"328\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The action in AMC's bonds suggests bankruptcy is a growing possibility</h3>\n<p>To be upfront, AMC has issued a lot of debt, with a variety of interest rates and maturity dates. The vast majority of the company's debt that would need to be paid off in the near term isn't of concern to Wall Street. That's because AMC has in the neighborhood of $2.2 billion in cash and cash equivalents after multiple cash raises, albeit this figure doesn't take into account its cash outflow in the second quarter, after burning through almost $325 million in the first quarter.</p>\n<p>Where trouble begins arising is if you look out to the company's bonds with maturity dates in 2026 and 2027. When bonds are issued, they're almost always priced at face value (100, or 100% of the face value of the bond). AMC's 2026 and 2027 bonds are nowhere close to face value anymore.</p>\n<p>A bond offering of $595 million with a maturity date of Nov. 15, 2026 had been as high as 76.19 (about 76% of face value) on June 21. That same bond now goes for 54.63 (below 55% of face value), as of July 20.</p>\n<p>Want another example? A $475 million debt offering with a May 15, 2027 maturity date was as high as 78.48 on June 23. However, it's been plummeting since July 6, with the July 20 bond price closing at 53.77.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F634412%2Fmoney-under-chain-and-lock-debt-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>You don't have to be a bond trader to read between the lines. With over $1 billion of AMC's debt trading at roughly one-half of par value, bondholders are clearly concerned the company won't have the capital to meet its debt obligations.</p>\n<p>And make no mistake about it, bondholders have every right to be concerned. AMC's apes have done everything in their power to deny AMC CEO Adam Aron the ability to sell stock in order to raise capital. What capital raises Aron did push through were done without having to get the approval of the company's retail investors. However, with AMC effectively maxed out on the share issuance front, it'll be forced to repay over $5.4 billion in debt entirely with cash, rather than stock. Considering the company is burning cash at an extraordinary rate, the math to avoid bankruptcy doesn't add up -- and apes simply don't get it.</p>\n<p>AMC bulls and bears can argue all day about the company, but the bond market speaks the truth about where AMC is headed.</p>\n<p><img src=\"https://static.tigerbbs.com/cc0c2c89dfba03fc4b0c9fb1c7b014cc\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>And don't forget the misinformation campaign...</h3>\n<p>If the truth isn't enough to persuade you of how awful an investment AMC is, perhaps surveying the mountain of myths and misinformation spread by its retail following will demonstrate how desperate this group is to artificially manipulate the company's share price.</p>\n<p>For example, AMC's retail cohort constantly asserts that a large number of naked short shares exist. They also believe that failure to delivers (FTDs) are endemic of naked short-selling, and that dark pool trading represents nefarious activity. Naturally, none of these assertions can ever be substantiated, but that doesn't stop these folks from spreading inaccurate information on social media in an attempt to bring in new capital.</p>\n<p>Working backwards, dark pool trading has no impact on supply and demand for retail trading. As for FTDs, clerical/administrative delays for high-volume stocks are common, as is human error and even buyer-based FTDs. And no naked short-selling campaign is ongoing if AMC's shares are available to short (and here's a hint: they've regularly been available). This entire thesis of alleged wrongdoing by apes is easily debunked.</p>\n<p>Just as ridiculous is the incorrect idea that hedge funds bankrupt companies. Businesses control their own destiny via their operating model and actions. A company's share price, including the buying and selling activity of that stock, doesn't determine if it's a success or not. Claiming short selling is the problem while completely ignoring the real reasons a company is struggling is yet another example of AMC's apes spreading false information online in an effort to rally support and fresh capital for their stock.</p>\n<p>With apes unable to substantiate any of their claims and the bond market flashing big warning signs, my outlook for AMC remains unchanged: Bankruptcy is still very much on the table.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Damaging AMC Entertainment Data Point No One Is Paying Attention To</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Damaging AMC Entertainment Data Point No One Is Paying Attention To\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 21:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/damaging-amc-data-point-no-one-paying-attention-to/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For nearly six months, meme stocks -- companies lauded more for the buzz they create on social media than their financial performance -- have been the talk of Wall Street. Often sporting high levels ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/damaging-amc-data-point-no-one-paying-attention-to/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/07/23/damaging-amc-data-point-no-one-paying-attention-to/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153498346","content_text":"For nearly six months, meme stocks -- companies lauded more for the buzz they create on social media than their financial performance -- have been the talk of Wall Street. Often sporting high levels of short interest and poor outlooks, these meme stocks have been lifted up by an army of retail investors.\nAlthough there seems to be a new meme stock in play every day, movie theater chain AMC Entertainment (NYSE:AMC) has consistently been the most popular.\n\nImage source: Getty Images.\nHope for a short squeeze is dwindling\nWhy AMC? According to its impassioned following, the company is purportedly ripe for a short squeeze. For those who may not be following AMC closely, the company's share price did squeeze short sellers (i.e., pessimists betting the share price will decline) in late January, shortly after the company saved itself from immediate bankruptcy by selling stock and issuing high-interest debt.\nThe problem for this emotion-driven group of AMC enthusiasts, who call themselves \"apes\" -- a nod to Rise of the Planet of the Apes and the idea that apes are stronger together -- is that the prospect for a short squeeze on AMC is pretty poor. Between the end of May and the end of June, New York Stock Exchange-reported data shows that shares held short declined from 102.3 million to approximately 75.5 million... and the price of AMC fell!\nShort sellers have to feel trapped in their positions for a squeeze to occur, and that's simply not happening with short interest on the decline and the short ratio (also known as \"days to cover\") well below one. There's not a data point more closely followed by AMC shareholders than its short interest.\nWhat isn't being paid attention to, but is far more damaging to AMC and its shareholders, is the absolute rout in some of the company's bonds over the past two weeks.\n\nImage source: Getty Images.\nThe action in AMC's bonds suggests bankruptcy is a growing possibility\nTo be upfront, AMC has issued a lot of debt, with a variety of interest rates and maturity dates. The vast majority of the company's debt that would need to be paid off in the near term isn't of concern to Wall Street. That's because AMC has in the neighborhood of $2.2 billion in cash and cash equivalents after multiple cash raises, albeit this figure doesn't take into account its cash outflow in the second quarter, after burning through almost $325 million in the first quarter.\nWhere trouble begins arising is if you look out to the company's bonds with maturity dates in 2026 and 2027. When bonds are issued, they're almost always priced at face value (100, or 100% of the face value of the bond). AMC's 2026 and 2027 bonds are nowhere close to face value anymore.\nA bond offering of $595 million with a maturity date of Nov. 15, 2026 had been as high as 76.19 (about 76% of face value) on June 21. That same bond now goes for 54.63 (below 55% of face value), as of July 20.\nWant another example? A $475 million debt offering with a May 15, 2027 maturity date was as high as 78.48 on June 23. However, it's been plummeting since July 6, with the July 20 bond price closing at 53.77.\n\nImage source: Getty Images.\nYou don't have to be a bond trader to read between the lines. With over $1 billion of AMC's debt trading at roughly one-half of par value, bondholders are clearly concerned the company won't have the capital to meet its debt obligations.\nAnd make no mistake about it, bondholders have every right to be concerned. AMC's apes have done everything in their power to deny AMC CEO Adam Aron the ability to sell stock in order to raise capital. What capital raises Aron did push through were done without having to get the approval of the company's retail investors. However, with AMC effectively maxed out on the share issuance front, it'll be forced to repay over $5.4 billion in debt entirely with cash, rather than stock. Considering the company is burning cash at an extraordinary rate, the math to avoid bankruptcy doesn't add up -- and apes simply don't get it.\nAMC bulls and bears can argue all day about the company, but the bond market speaks the truth about where AMC is headed.\n\nImage source: Getty Images.\nAnd don't forget the misinformation campaign...\nIf the truth isn't enough to persuade you of how awful an investment AMC is, perhaps surveying the mountain of myths and misinformation spread by its retail following will demonstrate how desperate this group is to artificially manipulate the company's share price.\nFor example, AMC's retail cohort constantly asserts that a large number of naked short shares exist. They also believe that failure to delivers (FTDs) are endemic of naked short-selling, and that dark pool trading represents nefarious activity. Naturally, none of these assertions can ever be substantiated, but that doesn't stop these folks from spreading inaccurate information on social media in an attempt to bring in new capital.\nWorking backwards, dark pool trading has no impact on supply and demand for retail trading. As for FTDs, clerical/administrative delays for high-volume stocks are common, as is human error and even buyer-based FTDs. And no naked short-selling campaign is ongoing if AMC's shares are available to short (and here's a hint: they've regularly been available). This entire thesis of alleged wrongdoing by apes is easily debunked.\nJust as ridiculous is the incorrect idea that hedge funds bankrupt companies. Businesses control their own destiny via their operating model and actions. A company's share price, including the buying and selling activity of that stock, doesn't determine if it's a success or not. Claiming short selling is the problem while completely ignoring the real reasons a company is struggling is yet another example of AMC's apes spreading false information online in an effort to rally support and fresh capital for their stock.\nWith apes unable to substantiate any of their claims and the bond market flashing big warning signs, my outlook for AMC remains unchanged: Bankruptcy is still very much on the table.","news_type":1},"isVote":1,"tweetType":1,"viewCount":420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}